CORC

在结果中检索

CORC

浏览/检索结果: 共57条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A c-MET-Targeted Topical Fluorescent Probe cMBP-ICG Improves Oral Squamous Cell Carcinoma Detection in Humans 期刊论文
ANNALS OF SURGICAL ONCOLOGY, 2022, 页码: 11
作者:  Wang, Jingbo;  Li, Siyi;  Wang, Kun;  Zhu, Ling;  Yang, Lin
收藏  |  浏览/下载：30/0  |  提交时间：2022/11/14
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Preoperative Prediction of Malignant Transformation of Sinonasal Inverted Papilloma Using MR Radiomics 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12, 页码: 10
作者:  Yan, Yang;  Liu, Yujia;  Tao, Jianhua;  Li, Zheng;  Qu, Xiaoxia
收藏  |  浏览/下载：22/0  |  提交时间：2022/06/10
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database 期刊论文
OPEN MEDICINE, 2021, 卷号: 16
作者:  Lei, Lei;  Yang, Liu;  Xu, Yang-yang;  Chen, Hua-fei;  Zhan, Ping
收藏  |  浏览/下载：4/0  |  提交时间：2022/12/23
NSCLC  HAL  SEER  survival  
Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells 期刊论文
BIOMED RESEARCH INTERNATIONAL, 2019
作者:  Zhang, Qing-Ling;  Lian, De-De;  Zhu, Ming Ji;  Li, Xue Mei;  Lee, Jae Kyung
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma 期刊论文
ONCOLOGY RESEARCH AND TREATMENT, 2019, 卷号: 42, 期号: 3
作者:  Sun, Si;  Yu, Hui;  Wang, Huijie;  Zhang, Hai;  Wu, Xianghua
收藏  |  浏览/下载：47/0  |  提交时间：2019/12/05
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer 期刊论文
2019, 卷号: 14, 期号: 1, 页码: 146
作者:  Fu, Jingxuan;  Wang, Weiping;  Wang, Yidan;  Liu, Chengeng;  Wang, Peichang
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31
Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer 期刊论文
EUROPEAN RADIOLOGY, 2018, 卷号: 28, 期号: 7, 页码: 2772-2778
作者:  Zhu, Xinzhong;  Dong, Di;  Chen, Zhendong;  Fang, Mengjie;  Zhang, Liwen
收藏  |  浏览/下载：39/0  |  提交时间：2018/10/10
Afatinib versus erlotinib as second-line treatment of patients (pts) with advanced lung squamous cell carcinoma (SCC): Final analysis of the global phase III LUX-Lung 8 (LL8) trial 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29
作者:  Cseh, A.;  Felip, E.;  Bender, S.;  Goss, G. D.;  Cobo, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace